Meiji Seika Pharma Sets up a New Subsidiary in the US
The Pharma Data
JANUARY 4, 2021
for expanding activities in the US with its initial focus on facilitating clinical development. Burr Boulevard, Teaneck, NJ 07666 (3) President: Yasushi Miyazawa (4) Scope of business: Clinical research and development (5) Paid in capital: US$100,000. (2) Location: 500 Frank W.
40 
Let's personalize your content